NCT04496687

Brief Summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
2 countries

31 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Mar 2019Dec 2026

Study Start

First participant enrolled

March 8, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 29, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 3, 2020

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

7.8 years

First QC Date

July 29, 2020

Last Update Submit

May 4, 2026

Conditions

Keywords

spontaneous coronary artery dissection (SCAD)myocardial infarctionsudden cardiac arrestacute coronary syndrome

Outcome Measures

Primary Outcomes (3)

  • Descriptive Data

    Participant demographic, historical, clinical characteristics, and treatment data

    Continuous time frame following index event for an average of 3 years from study contact date

  • Clinical Outcomes

    Prospectively collected long-term outcomes including recurrent myocardial infarction, hospitalization, heart failure, stroke or transient ischemic attack, arrhythmia, and all cause mortality

    Continuous time frame following index event for an average of 3 years from study contact date

  • Psychosocial Outcomes

    Prospectively collected data on participant's mental health using validated questionnaires

    Continuous time frame following index event for an average of 3 years from study contact date

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Spontaneous coronary artery dissection (SCAD) is defined as the non-traumatic, non-iatrogenic separation of the coronary arterial wall by intramural hemorrhage creating a false lumen, with or without an intimal tear. SCAD nearly always presents as an acute myocardial infarction. The prevalence of SCAD varies depending on the population studied. A goal of iSCAD Registry is to expand diversity of race, ethnicity, and sex of study participants. The mean age of SCAD presentation is 45-53 years of age, and appears to primarily affect women.

You may qualify if:

  • Participants with a new diagnosis of SCAD or a history of confirmed or suspected SCAD will be prospectively recruited from either:
  • Inpatient wards of the enrolling medical centers during the acute presentation of SCAD, or
  • Outpatient cardiovascular clinics of enrolling medical centers.
  • Participants must be:
  • years of age or older
  • Diagnosis of SCAD or history of SCAD based on coronary angiography, either catheter-based or coronary CTA
  • Suspected SCAD by coronary angiography

You may not qualify if:

  • Coronary dissection in association with atherosclerosis or as a result of iatrogenic injury
  • Inability to provide informed consent
  • Inability to complete study-related patient questionnaires
  • Inability to understand and complete patient questionnaires independently

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (31)

Cedars Sinai

Los Angeles, California, 90048, United States

Location

UCLA (University of California, Los Angeles)

Los Angeles, California, 93003, United States

Location

Kaiser Permanente Northern California

San Francisco, California, 94115, United States

Location

University of Colorado

Aurora, Colorado, 80045, United States

Location

Hartford Hospital

Hartford, Connecticut, 06106, United States

Location

University of South Florida

Tampa, Florida, 33602, United States

Location

Emory Healthcare System

Atlanta, Georgia, 30308, United States

Location

Northwestern Medicine

Chicago, Illinois, 60611, United States

Location

University of Kentucky

Lexington, Kentucky, 40508, United States

Location

Johns Hopkins

Baltimore, Maryland, 21224, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114-2696, United States

Location

St. Luke's Mid America

Kansas City, Missouri, 64111, United States

Location

Washington University

St Louis, Missouri, 63110, United States

Location

Dartmouth-Hitchcock

Lebanon, New Hampshire, 03756, United States

Location

Catholic Medical Center

Manchester, New Hampshire, 03102, United States

Location

Mount Sinai

New York, New York, 10029-6574, United States

Location

Columbia University Medical Center

New York, New York, 10032, United States

Location

Atrium Health Sanger Heart and Vascular Institute

Charlotte, North Carolina, 28204, United States

Location

University Hospitals--Case Western

Cleveland, Ohio, 44106, United States

Location

Oklahoma Heart

Oklahoma City, Oklahoma, 73120, United States

Location

Providence

Portland, Oregon, 97225, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Allegheny General Hospital, Allegheny Health Network

Pittsburgh, Pennsylvania, 15212, United States

Location

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

UT Southwestern

Dallas, Texas, 75390, United States

Location

Intermountain

Murray, Utah, 84107, United States

Location

University of Virginia

Charlottesville, Virginia, 22908, United States

Location

Inova Heart & Vascular Institute

Fairfax, Virginia, 22031, United States

Location

University of Washington Medicine

Seattle, Washington, 98195, United States

Location

Victor Chang Cardiac Research Institute

Darlinghurst, New South Wales, NSW 2010, Australia

Location

Related Publications (1)

  • Sumner JA, Kim ESH, Wood MJ, Chi G, Nolen J, Grodzinsky A, Gornik HL, Kadian-Dodov D, Wells BJ, Hess CN, Lewey J, Tam L, Henkin S, Orford J, Wells G, Kumbhani DJ, Lindley KJ, Gibson CM, Leon KK, Naderi S. Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry. J Am Heart Assoc. 2024 Apr 2;13(7):e032819. doi: 10.1161/JAHA.123.032819. Epub 2024 Mar 27.

Related Links

MeSH Terms

Conditions

Coronary Artery Dissection, SpontaneousMyocardial InfarctionDeath, Sudden, CardiacAcute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisHeart ArrestDeath, SuddenDeath

Study Officials

  • Esther Kim, MD

    Chair, Steering Committee

    STUDY CHAIR
  • Malissa Wood, MD

    Member, Steering Committee

    PRINCIPAL INVESTIGATOR
  • Sahar Naderi, MD

    Member, Steering Committee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2020

First Posted

August 3, 2020

Study Start

March 8, 2019

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 6, 2026

Record last verified: 2026-05

Locations